Michael Carleton
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Genetics top 1%
- Glioma Diagnosis and Treatment
Papers in
- Immunology 17
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 4
- Co-authors
- Peter S. Linsley (10 shared papers)Michele A. Cleary (7 shared papers)David L. Wiest (11 shared papers)Janell M. Schelter (4 shared papers)Aimee L. Jackson (3 shared papers)Mariëlle C. Haks (4 shared papers)John H. Sampson (2 shared papers)Solmaz Sahebjam (2 shared papers)
- Journals
- Journal of Virology (4 papers)The Journal of Immunology (4 papers)Journal of Clinical Oncology (3 papers)International Immunology (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesSpainCanada
In The Last Decade
Michael Carleton
37 papers receiving 3.8k citations
Michael Carleton's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 1.2k
- Genetics 612
- Immunology 1.1k
- Oncology 916
- Molecular Biology 1.7k
Countries citing papers authored by Michael Carleton
This map shows the geographic impact of Michael Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Carleton more than expected).
Fields of papers citing papers by Michael Carleton
This network shows the impact of papers produced by Michael Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Carleton. The network helps show where Michael Carleton may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Carleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma Hit paper breakdown → | 2020 | 980 |
| 2 | 2007 | 451 | |
| 3 | Elevated serum interleukin-8 is associated with enhanced intratumor neutrophils and reduced clinical benefit of immune-checkpoint inhibitors Hit paper breakdown → | 2020 | 361 |
| 4 | 2008 | 285 | |
| 5 | 2007 | 285 | |
| 6 | 2009 | 235 | |
| 7 | 2005 | 194 | |
| 8 | 2004 | 106 | |
| 9 | 2006 | 102 | |
| 10 | 2000 | 99 | |
| 11 | 2015 | 92 | |
| 12 | 2002 | 80 | |
| 13 | 2013 | 64 | |
| 14 | 1997 | 53 | |
| 15 | 2013 | 53 | |
| 16 | Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro. | 1999 | 53 |
| 17 | 1999 | 49 | |
| 18 | 2005 | 48 | |
| 19 | 1999 | 36 | |
| 20 | 2007 | 28 |
About Michael Carleton
Michael Carleton is a scholar working on Immunology, Molecular Biology, Oncology, Cancer Research and Plant Science, having authored 38 papers that have together received 3.8k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (8 papers), MicroRNA in disease regulation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (4 papers), Plant Virus Research Studies (3 papers) and Bacteriophages and microbial interactions (3 papers). The work is most often cited by research in Cancer Research (1.2k citations), Genetics (612 citations), Immunology (1.1k citations), Oncology (916 citations) and Molecular Biology (1.7k citations). Michael Carleton has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Peter S. Linsley, Michele A. Cleary, David L. Wiest, Janell M. Schelter, Aimee L. Jackson, Mariëlle C. Haks, John H. Sampson, Solmaz Sahebjam, Joachim M. Baehring and Michael Lim. Their work appears in journals such as Journal of Virology, The Journal of Immunology, Journal of Clinical Oncology, International Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.